Perspective Therapeutics to Participate in Upcoming May Investor Conferences
Perspective Therapeutics (NYSE: CATX), a radiopharmaceutical company focused on advanced cancer treatments, announced its participation in two major healthcare investor conferences in May 2025. The company's senior leadership will be available for one-on-one meetings with investors at both events.
The first appearance will be at the Bank of America Global Healthcare Conference in Las Vegas on May 13, featuring a 15-minute fireside chat at 11:35 a.m. PT. The second presentation will be at the 2025 RBC Capital Markets Global Healthcare Conference in New York on May 20, with a 25-minute fireside chat scheduled for 3:05 p.m. ET.
Perspective Therapeutics (NYSE: CATX), un'azienda radiopharmaceutica specializzata in trattamenti avanzati per il cancro, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a maggio 2025. I dirigenti senior dell'azienda saranno disponibili per incontri individuali con gli investitori in entrambi gli eventi.
La prima apparizione avverrà alla Bank of America Global Healthcare Conference a Las Vegas il 13 maggio, con una chiacchierata informale di 15 minuti alle 11:35 ora del Pacifico. La seconda presentazione si terrà alla 2025 RBC Capital Markets Global Healthcare Conference a New York il 20 maggio, con una chiacchierata informale di 25 minuti prevista per le 15:05 ora della costa est.
Perspective Therapeutics (NYSE: CATX), una empresa radiofarmacéutica centrada en tratamientos avanzados contra el cáncer, anunció su participación en dos importantes conferencias para inversores en el sector salud en mayo de 2025. Los altos directivos de la compañía estarán disponibles para reuniones individuales con inversores en ambos eventos.
La primera aparición será en la Bank of America Global Healthcare Conference en Las Vegas el 13 de mayo, con una charla informal de 15 minutos a las 11:35 a.m. hora del Pacífico. La segunda presentación será en la 2025 RBC Capital Markets Global Healthcare Conference en Nueva York el 20 de mayo, con una charla informal de 25 minutos programada para las 3:05 p.m. hora del Este.
Perspective Therapeutics (NYSE: CATX)는 첨단 암 치료에 주력하는 방사성 의약품 회사로, 2025년 5월 두 개의 주요 의료 투자자 컨퍼런스에 참여할 것임을 발표했습니다. 회사의 고위 경영진은 두 행사 모두에서 투자자들과 일대일 미팅을 진행할 예정입니다.
첫 번째 참석은 5월 13일 라스베이거스에서 열리는 Bank of America Global Healthcare Conference로, 태평양 표준시 오전 11시 35분에 15분간의 대화 세션이 예정되어 있습니다. 두 번째 발표는 5월 20일 뉴욕에서 열리는 2025 RBC Capital Markets Global Healthcare Conference로, 동부 표준시 오후 3시 5분에 25분간의 대화 세션이 예정되어 있습니다.
Perspective Therapeutics (NYSE: CATX), une entreprise radiopharmaceutique spécialisée dans les traitements avancés contre le cancer, a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé en mai 2025. La haute direction de la société sera disponible pour des rencontres individuelles avec les investisseurs lors des deux événements.
La première intervention aura lieu à la Bank of America Global Healthcare Conference à Las Vegas le 13 mai, avec une discussion informelle de 15 minutes à 11h35, heure du Pacifique. La deuxième présentation se tiendra à la 2025 RBC Capital Markets Global Healthcare Conference à New York le 20 mai, avec une discussion informelle de 25 minutes prévue à 15h05, heure de l’Est.
Perspective Therapeutics (NYSE: CATX), ein radiopharmazeutisches Unternehmen, das sich auf fortschrittliche Krebstherapien spezialisiert hat, gab seine Teilnahme an zwei wichtigen Gesundheitsinvestorenkonferenzen im Mai 2025 bekannt. Die Führungskräfte des Unternehmens stehen bei beiden Veranstaltungen für Einzelgespräche mit Investoren zur Verfügung.
Der erste Auftritt findet auf der Bank of America Global Healthcare Conference in Las Vegas am 13. Mai statt, mit einem 15-minütigen Gespräch um 11:35 Uhr Pazifischer Zeit. Die zweite Präsentation erfolgt auf der 2025 RBC Capital Markets Global Healthcare Conference in New York am 20. Mai, mit einem 25-minütigen Gespräch um 15:05 Uhr Eastern Time.
- None.
- None.
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate and be available for one-on-one meetings with investors at the following upcoming investor conferences.
Bank of America Global Healthcare Conference
Date: Tuesday, May 13, 2025
Format: Fireside Chat
Time: 11:35 a.m. – 11:50 a.m. PT / 2:35 p.m. – 2:50 p.m. ET
Location: Las Vegas, NV
2025 RBC Capital Markets Global Healthcare Conference
Date: Tuesday, May 20, 2025
Format: Fireside Chat
Time: 3:05 p.m. - 3:30 p.m. ET
Location: New York, NY
About Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. is a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. The Company is also developing complementary imaging diagnostics that incorporate the same targeting moieties, which provides the opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity.
The Company's melanoma (VMT01), neuroendocrine tumor (VMT-α-NET), and solid tumor (PSV359) programs are in Phase 1/2a imaging and therapy trials in the U.S. The Company is growing its regional network of drug product finishing facilities, enabled by its proprietary 212Pb generator, to deliver patient-ready products for clinical trials and commercial operations.
For more information, please visit the Company's website at www.perspectivetherapeutics.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include statements concerning, among other things, the Company's ability to pioneer advanced treatments for cancers throughout the body; the ability of the Company's proprietary technology utilizing the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties; the Company's prediction that the use of complementary imaging diagnostics that incorporate the same targeting moieties provides the opportunity to personalize treatment and optimize patient outcomes; the Company's belief that its "theranostic" approach enables the ability to see a specific tumor and then treat it to potentially improve efficacy and minimize toxicity; the Company's ability to grow its regional network of drug product finishing facilities, enabled by its proprietary 212Pb generator, to deliver patient-ready products for clinical trials and commercial operations; and other statements that are not historical fact.
These forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from the results described in or implied by the forward-looking statements. Certain factors that may cause the Company's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are described under the heading "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC"), in the Company's other filings with the SEC, and in the Company's future reports to be filed with the SEC and available at www.sec.gov. Forward-looking statements contained in this news release are made as of this date. Unless required to do so by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Media and Investor Relations Contacts:
Perspective Therapeutics IR:
Annie J. Cheng, CFA
ir@perspectivetherapeutics.com
Russo Partners, LLC
Nic Johnson
PerspectiveIR@russopr.com
FAQ
What investor conferences will Perspective Therapeutics (CATX) attend in May 2025?
When is Perspective Therapeutics (CATX) presenting at the Bank of America Healthcare Conference?
What time is Perspective Therapeutics (CATX) presenting at the RBC Healthcare Conference?
Will investors be able to meet with Perspective Therapeutics (CATX) management at the May 2025 conferences?
